Mushroom toxicity

Background

Major Categories

  • Early-Onset Poisoning
    • Toxicity begins within 2hr of ingestion; clinical course is usually benign
  • Late-Onset Poisoning
    • Toxicity begins 6hr after ingestion; clinical course is often serious/ possibly fatal
Mushroom Toxin Pathologic Effect
Amatoxin Hepatotoxicity
Coprine Disulfiram-like
Gyromitrin Seizures
Ibotenic Acid Anticholinergic
Muscarine Cholinergic
Orellanin Nephrotoxicity
Psilocybin Hallucinations

Specific Mushroom Type Ingestions

Differential Diagnosis

Causes of acute hepatitis

Diagnosis

Cortinarius mushroom Gyromitra mushrooms Amanita phalloides aka death cap

Early-Onset Poisoning

  • Comprises majority of mushroom-induced intoxications
  • Symptom onset 30-90 min with hallucinations, lasting 6-8 hrs[2]:
    • Isoxazoles (ibotenic acid and muscimol) - dsyarthria, ataxia, muscle cramps
    • Psilocybin - euphoria, visual hallucinations, agitation, sympathomimetic Sxs

Clinical Features

  • Depends on the type of mushroom ingested
  • GI
    • Nausea/vomiting/diarrhea
    • Resolves within 24hr
  • CNS
    • Euphoria, hallucinations
    • Lasts 4-6hr
  • Muscarinic
    • SLUDGE symptoms
    • Diaphoresis, muscle fasciculations, miosis, bradycardia, bronchorrhea
    • Resolves in 4-12hr
  • Disulfiram-like effect
    • Usually when drinking alcohol
    • Flushing, tachycardia, diaphoresis, hypotension

Treatment

  • GI predominant symptoms:
    • Activated charcoal 0.5-1gm/kg
    • Do not give antidiarrheal meds
  • CNS predominant symptoms:
    • Place in dark, quiet room
    • Benzos may be given to pts who are agitated
  • Muscarinic predominant symptoms:
    • Consider atropine for severe symptoms; 0.5-1mg IV for adults; 0.01mg/kg IV for peds

Disposition

  • Discharge once symptoms have subsided

Delayed-Onset Poisoning

  • Amanita species causes 95% of deaths
    • Toxin inhibits formation of mRNA and is heat stable
    • Most frequent species: A. phalloides, bisporigera, magnivelaris, ocreata, verna, virosa[3]

References

  1. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002 Dec 17; 137(12): 947-54.
  2. Rolston-Cregler L et al. Hallucinogenic Mushroom Toxicity. Apr 08, 2015. http://emedicine.medscape.com/article/817848-overview.
  3. Enjalbert F et al. Treatment of Amatoxin Poisoning: 20 year retrospective analysis. J tox Clin Tox 2002 40(6):715-767.